gamma-aminobutyric acid has been researched along with Bodily Distress Disorder in 3 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Patients of the first group received adaptol in dosage 1000 mg daily and patients of the second group received noofen in dosage 500 mg daily." | 2.79 | [Asthenic disorders in children and their differentiated treatment]. ( Anisimova, TI; Bondarchuk, IL; Chutko, LS; Iakovenko, EA; Nikishena, IS; Sergeev, AV; Surushkina, SI, 2014) |
| "The higher efficacy of adaptol in treatment of neurasthenia (80% in adolescents with neurasthenia and 60% of patients with residual asthenia) was shown." | 2.79 | [Asthenic disorders in children and their differentiated treatment]. ( Anisimova, TI; Bondarchuk, IL; Chutko, LS; Iakovenko, EA; Nikishena, IS; Sergeev, AV; Surushkina, SI, 2014) |
| "Authors examined 30 adolescents with neurasthenia and 30 with residual asthenia." | 2.79 | [Asthenic disorders in children and their differentiated treatment]. ( Anisimova, TI; Bondarchuk, IL; Chutko, LS; Iakovenko, EA; Nikishena, IS; Sergeev, AV; Surushkina, SI, 2014) |
| "Adolescents with neurasthenia were characterized by higher anxiety." | 2.79 | [Asthenic disorders in children and their differentiated treatment]. ( Anisimova, TI; Bondarchuk, IL; Chutko, LS; Iakovenko, EA; Nikishena, IS; Sergeev, AV; Surushkina, SI, 2014) |
| "Pivagabine 1800 mg/d was administered orally for four weeks." | 2.68 | Randomised, double-blind, placebo-controlled study of pivagabine in neurasthenia. ( Albano, C; Avanzi, S; Caffarra, P; Cagnin, A; Ciappina, C; Copelli, S; Cultrera, S; D'Antonio, E; Di Costanzo, E; Fracassi, M; Lo Presti, F; Mancia, D; Matrango, M; Pastres, P; Pizzolato, G; Provinciali, L; Regnicolo, L; Roccatagliata, G; Rubino, V; Signorino, M; Simoncelli, M; Spilimbergo, PG; Urbani, PP, 1997) |
| "One hundred and eighteen patients with neurasthenia, as defined by ICD 10 (International Classification of Diseases), participated in a randomised, double-blind, placebo-controlled trial of pivagabine (4-[(2,2-dimethyl-1-oxopropyl)amino]butanoic acid, CAS 69542-93-4, Tonerg)." | 2.68 | Randomised, double-blind, placebo-controlled study of pivagabine in neurasthenia. ( Albano, C; Avanzi, S; Caffarra, P; Cagnin, A; Ciappina, C; Copelli, S; Cultrera, S; D'Antonio, E; Di Costanzo, E; Fracassi, M; Lo Presti, F; Mancia, D; Matrango, M; Pastres, P; Pizzolato, G; Provinciali, L; Regnicolo, L; Roccatagliata, G; Rubino, V; Signorino, M; Simoncelli, M; Spilimbergo, PG; Urbani, PP, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chutko, LS | 2 |
| Surushkina, SI | 1 |
| Nikishena, IS | 2 |
| Iakovenko, EA | 2 |
| Anisimova, TI | 2 |
| Bondarchuk, IL | 1 |
| Sergeev, AV | 1 |
| Surushkina, SIu | 1 |
| Kuzovenkova, MP | 1 |
| Pizzolato, G | 1 |
| Cagnin, A | 1 |
| Mancia, D | 1 |
| Caffarra, P | 1 |
| Avanzi, S | 1 |
| Copelli, S | 1 |
| Ciappina, C | 1 |
| Lo Presti, F | 1 |
| Spilimbergo, PG | 1 |
| D'Antonio, E | 1 |
| Di Costanzo, E | 1 |
| Matrango, M | 1 |
| Pastres, P | 1 |
| Urbani, PP | 1 |
| Signorino, M | 1 |
| Simoncelli, M | 1 |
| Provinciali, L | 1 |
| Regnicolo, L | 1 |
| Albano, C | 1 |
| Roccatagliata, G | 1 |
| Rubino, V | 1 |
| Cultrera, S | 1 |
| Fracassi, M | 1 |
3 trials available for gamma-aminobutyric acid and Bodily Distress Disorder
| Article | Year |
|---|---|
[Asthenic disorders in children and their differentiated treatment].
Topics: Adolescent; Anti-Anxiety Agents; Anxiety; Asthenia; Biureas; Fatigue; Female; GABA Agonists; gamma-A | 2014 |
[Asthenic disorders in children].
Topics: Adolescent; Asthenia; Biureas; Child; gamma-Aminobutyric Acid; Humans; Neurasthenia; Pantothenic Aci | 2010 |
Randomised, double-blind, placebo-controlled study of pivagabine in neurasthenia.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; gamma-Aminobutyric Acid; Humans; Male; Middle | 1997 |